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Introduction: The increasing prevalence of antipsychotic medication use in residents of nursing 
homes (NH) in the absence of psychiatric diagnoses is concerning.  To address these concerns, 
it is essential to explore how these medications are being prescribed and managed in the NH 
setting.  Our objectives were to understand the decision-making process that influences 
prescribing and factors that trigger administration of antipsychotic medications to residents with 
dementia in NHs and to explore why residents remain on antipsychotic medications over an 
extended period of time. 
Methods: Interviews with prescribers, caregivers, and family members, on-site observations in 
study facilities, and review of NH resident medical records. Facilities were selected to obtain a 
diverse sample of NHs. 
Results: 204 NH residents with dementia in 26 facilities distributed across five selected Centers 
for Medicaid and Medicare Services regions were included. Problematic behaviors were the 
dominant reasons offered as influencing prescribing of antipsychotic medications. Providers 
indicated that they chose an antipsychotic, rather than another drug class, because they 
believed that antipsychotic medications were more likely to be effective. There was no standard 
approach to taper attempts. Family members identified a lack of communication as a barrier to 
their involvement in decision-making. 
Conclusions: There is widespread perception that antipsychotic medications are effective and 
beneficial in managing problematic behaviors in NH residents with dementia. Little attention is 
given to planning for antipsychotic tapering or discontinuation. There may be opportunities to 
involve family members more fully in decision-making around the use of antipsychotic 
medications. 
  
 
